Key Points
- CFO Vikas Sinha sold 16,755 shares on Jan. 13 at an average price of $42.70 for $715,438.50, leaving him with 583,245 shares — a 2.79% reduction in his ownership.
- SRRK shares opened at $46.53 and trade in a one‑year range of $22.71–$48.28, with a market cap of $4.75 billion and a negative trailing PE of –14.77.
- Analysts hold an overall "Buy" consensus with an average target of $50.14, institutional investors own about 91.08% of the stock, and the company recently missed quarterly EPS (–$0.90 vs. –$0.88) with analysts forecasting –2.42 EPS for the fiscal year.
Scholar Rock Holding Corporation (NASDAQ:SRRK - Get Free Report) COO Keith Woods sold 16,746 shares of the stock in a transaction on Tuesday, January 13th. The shares were sold at an average price of $42.70, for a total value of $715,054.20. Following the transaction, the chief operating officer directly owned 583,254 shares of the company's stock, valued at approximately $24,904,945.80. This trade represents a 2.79% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.
Scholar Rock Stock Up 2.1%
Shares of NASDAQ SRRK opened at $46.53 on Friday. The company has a debt-to-equity ratio of 0.41, a current ratio of 6.30 and a quick ratio of 6.30. The stock has a market capitalization of $4.75 billion, a PE ratio of -14.77 and a beta of 0.63. Scholar Rock Holding Corporation has a one year low of $22.71 and a one year high of $48.28. The business's fifty day moving average price is $42.02 and its 200-day moving average price is $36.87.
Scholar Rock (NASDAQ:SRRK - Get Free Report) last announced its quarterly earnings data on Friday, November 14th. The company reported ($0.90) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.88) by ($0.02). During the same quarter last year, the company posted ($0.66) earnings per share. On average, equities research analysts anticipate that Scholar Rock Holding Corporation will post -2.42 EPS for the current year.
Wall Street Analysts Forecast Growth
A number of equities research analysts have issued reports on SRRK shares. Cantor Fitzgerald reissued an "overweight" rating on shares of Scholar Rock in a report on Thursday, December 11th. Barclays lifted their price target on Scholar Rock from $45.00 to $52.00 and gave the company an "overweight" rating in a research report on Wednesday, December 17th. Citigroup began coverage on Scholar Rock in a report on Friday, January 9th. They set a "buy" rating and a $55.00 price objective on the stock. Piper Sandler decreased their price target on Scholar Rock from $52.00 to $51.00 and set an "overweight" rating on the stock in a research report on Wednesday, September 24th. Finally, Bank of America began coverage on shares of Scholar Rock in a report on Thursday, October 9th. They issued a "buy" rating and a $53.00 price target on the stock. Four analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat, Scholar Rock presently has a consensus rating of "Buy" and an average target price of $50.14.
View Our Latest Stock Analysis on Scholar Rock
Hedge Funds Weigh In On Scholar Rock
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Moody Aldrich Partners LLC raised its position in Scholar Rock by 53.5% during the third quarter. Moody Aldrich Partners LLC now owns 101,742 shares of the company's stock valued at $3,789,000 after purchasing an additional 35,481 shares in the last quarter. Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. lifted its position in Scholar Rock by 145.3% in the 2nd quarter. Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. now owns 769,442 shares of the company's stock worth $27,254,000 after buying an additional 455,753 shares during the last quarter. Norges Bank purchased a new stake in Scholar Rock in the second quarter worth approximately $41,628,000. Voya Investment Management LLC grew its position in Scholar Rock by 18.1% during the third quarter. Voya Investment Management LLC now owns 443,155 shares of the company's stock valued at $16,503,000 after acquiring an additional 67,839 shares during the last quarter. Finally, Intech Investment Management LLC raised its stake in shares of Scholar Rock by 60.9% during the first quarter. Intech Investment Management LLC now owns 56,784 shares of the company's stock worth $1,826,000 after acquiring an additional 21,483 shares in the last quarter. Hedge funds and other institutional investors own 91.08% of the company's stock.
Scholar Rock Company Profile
(
Get Free Report)
Scholar Rock is a clinical-stage biotechnology company focused on the discovery and development of protein therapeutics that selectively target growth factors involved in disease processes. The company's research platform is designed to modulate endogenous growth factor activation and signaling with high specificity, aiming to restore normal biological function across a range of disorders. Scholar Rock's approach is distinguished by its emphasis on engineering antibodies and biologics that interact with growth factor precursors or latent complexes rather than the active form, potentially offering improved safety and efficacy profiles.
The company's lead program, SRK-015 (appercept), is an investigational monoclonal antibody targeting the activation of latent myostatin proproteins and is being evaluated for the treatment of spinal muscular atrophy (SMA).
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
